tradingkey.logo

Amylyx Pharmaceuticals Inc <AMLX.OQ> expected to post a loss of 52 cents a share - Earnings Preview

ReutersFeb 21, 2025 2:25 PM
  • Amylyx Pharmaceuticals Inc AMLX.OQ AMLX.O is expected to show a fall in quarterly revenue when it reports results on February 24 (estimated) for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for Amylyx Pharmaceuticals Inc is for a loss of 52 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Amylyx Pharmaceuticals Inc is $10.00​, above​ its last closing price of $3.52. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.75

-0.71

-1.07

Missed

-50.7

Jun. 30 2024

-0.64

-0.73

-0.73

Met

0

Mar. 31 2024

0.02

-0.01

-0.12

Missed

-1,900​

Dec. 31 2023

0.24

0.23

0.07

Missed

-69.3

​​Sep. 30 2023

0.43

0.44

0.30

Missed

-31

Jun. 30 2023

0.08

0.10

0.31

Beat

210​

Mar. 31 2023

-0.23

-0.24

0.02

Beat

108.3

Dec. 31 2022

-0.82

-0.82

-0.65

Beat

20.7

This summary was machine generated February 21 at 14:25 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI